|
October, 2005
MIV files patent for biocompatible stent coatings and drug delivery technologies
MIV Therapeutics
Patent Organization: US and international Patent Cooperation Treaty (PCT) Patent Applications
Patent Area: Intelligent drug delivery system, localized drug delivery, nanotechnology and pharmaceutical based
MIV Therapeutics, Inc.
Vancouver, Canada
Products: Smart III biocompatible stent coatings and drug delivery technologies allows for the storage and delivery of one or more drugs
End Markets: Capsules, medical device coatings, tablets, , Nanoparticle drug delivery system., drug elution technology. Layered based drug delivery.
MIV reported that advanced drug delivery systems sales are projected to be $86 billion in 2007, and more than $150 billion, Source: U.S. Dept. of Commerce
Exchange: OTCBB
Exchange Symbol: MIVT
|
|
